When Grey’s Anatomy returns for Season 22 this fall, there may be reason for fans to grieve another character loss. There were several surgeons in danger of being in the blast zone of the giant ...

The Italy Tractor Market, valued at 15,448 units in 2024, is expected to rise to 16,589 units by 2030, with a CAGR of 1.19%.

A 28-year-old man who started using the injectable medication on Saturday (7 June) has opened up on his experience so far ...

The Canon EOS R50 V Vlogging Camera is now available in black, priced at PHP 64,998.

The U.S. logged 122 more cases of measles this week — but only four of them in Texas — while the outbreaks in Pennsylvania ...

Weight-loss medications continue to grow in popularity as an anti-obesity tool — but are some more effective than others? The question was explored in a new study published this month in The New ...

The 63-year-old shared a recent photo of herself performing standup comedy, more than two years after she began losing weight with the help of Mounjaro, an anti-Type 2 diabetes GLP-1 medication.

Weight loss drugs are popular for helping patients quickly shed pounds Drugs like Ozempic are controversial for their side effects Side effects of some drugs can range from nausea to kidney ...

"FDA allowed these medicines out without a long-term strategy." Kessler faced unexpected weight gain while serving in his role co-leading Operation Warp Speed, the coronavirus vaccination program ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published, examining their ability to reduce weight and waist circumference.

The first head-to-head trial of two blockbuster weight-loss drugs has shown Mounjaro is more effective than rival Wegovy. Both drugs led to substantial weight loss, but Mounjaro's 20% weight ...

May 12, 2025 – Turns out, two really is better than one – at least when it comes to weight loss drugs. In the first head-to-head trial of its kind, people with obesity who took tirzepatide ...